Engineers Gate Manager LP Verastem, Inc. Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $24,700 - $48,934	-23,302 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $47,769 - $74,566	23,302 New	23,302 $48,000
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $43,436 - $69,601	-17,101 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $43,949 - $82,939	17,101 New	17,101 $70,000
Q4 2020 Feb 16, 2021	SELL	$1.15 - $2.4 $30,704 - $64,080	-26,700 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.11 - $1.68 $16,206 - $24,528	14,600 Added 120.66%	26,700 $32,000
Q2 2020 Aug 17, 2020	BUY	$1.69 - $4.2 $20,449 - $50,820	12,100 New	12,100 $21,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.12B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.